Cytek Biosciences, Inc. - Common Stock (CTKB)

167 filings reported holding CTKB - Cytek Biosciences, Inc. - Common Stock as of Q4 2024.
Cytek Biosciences, Inc. - Common Stock (CTKB) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 77.3M shares of 127M outstanding shares and own 60.99% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (18.5M shares), VANGUARD GROUP INC (11.7M shares), BROWN CAPITAL MANAGEMENT LLC (8.25M shares), HHLR ADVISORS, LTD. (6.66M shares), STATE STREET CORP (4.51M shares), GEODE CAPITAL MANAGEMENT, LLC (2.64M shares), NEW YORK STATE COMMON RETIREMENT FUND (2.09M shares), DIMENSIONAL FUND ADVISORS LP (1.83M shares), WELLINGTON MANAGEMENT GROUP LLP (1.52M shares), and GOLDMAN SACHS GROUP INC (1.34M shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.